바이오인

 Building on Opportunities in Cancer Research

AN ANNUAL PLAN AND BUDGET PROPOSAL FOR FISCALYEAR 2016

Foreword
This is a time of remarkable opportunity in cancer research. Armed with broad knowledge about how various kinds of cancer arise and with powerful new research tools, the cancer research community, under the leadership of the National Cancer Institute (NCI), is poised to reduce the burden of cancer in this country and around the world at an accelerated pace.

The NCI’s goal is to support research that ultimately leads to important clinical outcomes: improvements in prevention, diagnosis, and treatment that can reduce the incidence, morbidity, and mortality of all types of cancer. Making sustained progress, however, requires a wide range of research disciplines that span the continuum from basic science to clinical research to research on implementation and cancer care delivery.

They include a variety of basic sciences, such as genetics, genomics, cell biology, immunology, and nanotechnology; translational and clinical sciences, such as drug development and testing, diagnostics, and the discovery and development of molecular markers, advanced imaging technologies, and new radiotherapy techniques; population sciences, such as population genetics, epidemiology, and environmental sciences; and behavioral sciences. Virtually all major advances toward the goal of improving the prevention, diagnosis, and treatment of cancer depend on many kinds of science. Cancer research is also cumulative. Today’s investments in basic science will provide tomorrow’s opportunities in clinical research.

...................(계속)

☞ 자세한 내용은 내용바로가기 또는 첨부파일을 이용하시기 바랍니다.